ventricular apical ballooning

Ventricular apical ballooning syndrome, also known as Takotsubo cardiomyopathy, stress cardiomyopathy, or 'broken heart syndrome,' typically occurs following acute emotional or physical stress (e.g., death of a loved one, natural disasters, severe illness) and predominantly affects postmenopausal women. The proposed pathophysiology involves a catecholamine surge causing microvascular dysfunction, direct myocyte toxicity, and/or transient coronary vasospasm, leading to stunning of the apical myocardium which has a higher density of beta-adrenergic receptors, making it more susceptible to catecholamine-induced injury. Patients present with symptoms mimicking acute myocardial infarction—chest pain, dyspnea, ST-segment elevation on ECG, and elevated cardiac biomarkers (troponin)—but coronary angiography reveals no significant obstructive coronary artery disease. The characteristic echocardiographic finding is akinesis or dyskinesis of the LV apex and mid-ventricular segments with hyperkinesis of the basal segments, creating the apical ballooning appearance during systole. This condition is a diagnostic mimicker of STEMI and must be differentiated via coronary angiography. Most cases are reversible, with LV function typically normalizing within 1-4 weeks, though complications like cardiogenic shock, LV outflow tract obstruction, mitral regurgitation, ventricular arrhythmias, and even death can occur in the acute phase. Diagnosis is per the Mayo Clinic criteria, which include transient wall motion abnormalities extending beyond a single coronary vascular territory, absence of obstructive CAD, new ECG changes or modest troponin elevation, and absence of pheochromocytoma or myocarditis. Treatment is largely supportive, similar to heart failure management (beta-blockers, ACE inhibitors), avoiding inotropes if LVOT obstruction is present.